ID   NIKS-16deltaE7
AC   CVCL_B0UN
SY   BC-1-Ep/SL/HPV-16/E7TTL; 13-9
DR   GEO; GSM2197781
DR   GEO; GSM2197782
DR   GEO; GSM2197783
DR   Wikidata; Q108821046
RX   PubMed=10864676;
RX   PubMed=28623356;
CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [Note=With defective E7].
CC   Omics: Transcriptome analysis by microarray.
CC   Derived from site: In situ; Foreskin, skin, epidermis; UBERON=UBERON_0001471+UBERON_0001003.
CC   Cell type: Keratinocyte; CL=CL_0000312.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A1LW ! NIKS
SX   Male
AG   <1M
CA   Transformed cell line
DT   Created: 23-09-21; Last updated: 05-10-23; Version: 5
//
RX   PubMed=10864676; DOI=10.1128/JVI.74.14.6622-6631.2000;
RA   Flores E.R., Allen-Hoffmann B.L., Lee D., Lambert P.F.;
RT   "The human papillomavirus type 16 E7 oncogene is required for the
RT   productive stage of the viral life cycle.";
RL   J. Virol. 74:6622-6631(2000).
//
RX   PubMed=28623356; DOI=10.1038/s41598-017-03295-7;
RA   Cicchini L., Blumhagen R.Z., Westrich J.A., Myers M.E., Warren C.J.,
RA   Siska C., Raben D., Kechris K.J., Pyeon D.;
RT   "High-risk human papillomavirus E7 alters host DNA methylome and
RT   represses HLA-E expression in human keratinocytes.";
RL   Sci. Rep. 7:3633-3633(2017).
//